The S&P 500 rallied in the wake of last week's election results, climbing 3.8% since Nov. 5 at Wednesday's prices. But not ...

The VanEck Pharmaceutical ETF (PPH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity ...

Investors increased their allocations to pharmaceuticals (NYSEARCA:PJP), (NYSEARCA:XPH), (PPH), banks (KRE) and industrials ...

SPDR® S&P Biotech ETF is a well-diversified, low-cost ETF that can be an excellent tool to capitalize on the potential of the biotech stock sector. XBI's performance should be compared with the ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

VanEck Pharmaceutical ETF Price Performance PPH stock opened at $94.67 on Monday. The stock has a market capitalization of $728.01 million, a P/E ratio of 21.04 and a beta of 0.72. The business ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Nippon India NIFTY Pharma ETF Growth Plan share price previously? Nippon India NIFTY Pharma ETF Growth Plan share ...